Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00292357

Enrollment

Registered

2006-02-15

Start date

Unknown

Completion date

Unknown

Last updated

2010-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications, Diabetic Foot

Brief summary

Bone marrow cells were previously shown to enhance wound healing in experimental diabetes. In this pilot study, patients with chronic diabetic ulcers not healing under conventional therapy, will be treated with local application of autologous bone marrow cells.

Interventions

PROCEDUREApplication of autologous bone marrow

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diabetes mellitus * chronic non-healing foot ulcers (\>4weeks)

Exclusion criteria

* Charcot foot * Non-diabetic ulcers * Ulcers healing under conventional therapy * Sepsis * Hematologic disorders * Pregnancy * Acute inflammatory disorders * Chemotherapy

Design outcomes

Primary

Measure	Time frame
Safety and Feasibility	—
Healing velocity	—

Countries

Germany

Contacts

Primary ContactPer Humpert, MD

per.humpert@med.uni-heidelberg.de+49 6221 56

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026